| Matthew H Armstrong, MD | |
|
100 Michigan St Ne, Grand Rapids, MI 49503-2560 | |
| (616) 364-4200 | |
| Not Available |
| Full Name | Matthew H Armstrong |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 100 Michigan St Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003137720 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Michigan Anesthesia Pc | 1355243551 | 193 |
| Anesthesia Medical Consultants, Pc | 3678751658 | 87 |
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
Research led by Jimmy Gollihar from the CCDC Army Research Laboratory-South in Austin, Texas found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 —first detected last fall in England — increased in Houston, Texas. The B.1.1.7 variant is rapidly spreading with a case doubling time of 6.9 days.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
› Verified 4 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
Research led by Jimmy Gollihar from the CCDC Army Research Laboratory-South in Austin, Texas found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 —first detected last fall in England — increased in Houston, Texas. The B.1.1.7 variant is rapidly spreading with a case doubling time of 6.9 days.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
› Verified 4 days ago
| Entity Name | West Michigan Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225016926 PECOS PAC ID: 1355243551 Enrollment ID: O20040504001256 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
Research led by Jimmy Gollihar from the CCDC Army Research Laboratory-South in Austin, Texas found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 —first detected last fall in England — increased in Houston, Texas. The B.1.1.7 variant is rapidly spreading with a case doubling time of 6.9 days.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
› Verified 4 days ago
| Entity Name | Amc Mobile Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376868372 PECOS PAC ID: 9830372812 Enrollment ID: O20110329000600 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
Research led by Jimmy Gollihar from the CCDC Army Research Laboratory-South in Austin, Texas found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 —first detected last fall in England — increased in Houston, Texas. The B.1.1.7 variant is rapidly spreading with a case doubling time of 6.9 days.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
› Verified 4 days ago
| Entity Name | Anesthesia Medical Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063710689 PECOS PAC ID: 3678751658 Enrollment ID: O20110621000722 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
Research led by Jimmy Gollihar from the CCDC Army Research Laboratory-South in Austin, Texas found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 —first detected last fall in England — increased in Houston, Texas. The B.1.1.7 variant is rapidly spreading with a case doubling time of 6.9 days.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew H Armstrong, MD 1959 Ne Pacific St, Box 356540, Seattle, WA 98195-0001 Ph: (206) 221-6453 | Matthew H Armstrong, MD 100 Michigan St Ne, Grand Rapids, MI 49503-2560 Ph: (616) 364-4200 |
News Archive
Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock (the "Series 6 Financing"). The offering is scheduled to close on or about July 27, 2010, subject to the satisfaction of customary closing conditions.
The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.
Research led by Jimmy Gollihar from the CCDC Army Research Laboratory-South in Austin, Texas found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.7 —first detected last fall in England — increased in Houston, Texas. The B.1.1.7 variant is rapidly spreading with a case doubling time of 6.9 days.
Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.
› Verified 4 days ago
Daniel H. Robinson, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-5000 | |
Cheryl Lukins, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25 Michigan St Ne Ste 2200, Grand Rapids, MI 49503 Phone: 616-391-3245 | |
Dr. Jeffrey M Ricketts, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Christopher Ross Russo, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 710 Kenmoor Ave Se, Suite 200, Grand Rapids, MI 49546 Phone: 616-588-7246 Fax: 616-588-7086 | |
Samuel Lee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Michign St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 | |
Dr. Cindy Chu, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-5000 |